Pharmaceutical news

First detailed results from landmark Phase III DAPA-HF trial published

3rd September 2019

Study shows reduced mortality rates in people with type 2 diabetes with CVD risk

14th August 2019

Full CAROLINA outcome trial data reveal long-term CVD safety profile

12th June 2019

Sanofi launches highest unit capacity basal insulin pen for adults with diabetes

3rd June 2019

SGLT-2 inhibitors in type 1 diabetes position statement updated

28th May 2019

Research

Landmark phase 3 study shows ‘significant’ renal failure risk reduction in type 2 diabetes

16th April 2019

Up to a third of people with type 2 diabetes not taking prescriptions properly says study

3rd April 2019

Long-term ‘benefits’ of metformin in type 2 diabetes prevention

22nd March 2019

A runner

Pre-exercise basal insulin reduction improves control says study

20th March 2019

Pioneering app and meter technology ‘reduces hypoglycaemia’

21st February 2019

Results of major CVD study presented at DPC2018

14th November 2018

Pioneering technology explores new diabetes therapies

3rd October 2018

Diabetes hospitalisations ‘reduced’ by double-checking medications

18th September 2018

UK launch of major SGLT2 inhibitors trial data at DPC2018

17th September 2018

Type 2 diabetes drug prescription trends reflected in study

13th August 2018

SGLT2i tool developed after evidence review

23rd July 2018